Ziółkiewicz, A.; Niziński, P.; Soja, J.; Oniszczuk, T.; Combrzyński, M.; Kondracka, A.; Oniszczuk, A.
Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review. Metabolites 2024, 14, 346.
https://doi.org/10.3390/metabo14060346
AMA Style
Ziółkiewicz A, Niziński P, Soja J, Oniszczuk T, Combrzyński M, Kondracka A, Oniszczuk A.
Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review. Metabolites. 2024; 14(6):346.
https://doi.org/10.3390/metabo14060346
Chicago/Turabian Style
Ziółkiewicz, Agnieszka, Przemysław Niziński, Jakub Soja, Tomasz Oniszczuk, Maciej Combrzyński, Adrianna Kondracka, and Anna Oniszczuk.
2024. "Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review" Metabolites 14, no. 6: 346.
https://doi.org/10.3390/metabo14060346
APA Style
Ziółkiewicz, A., Niziński, P., Soja, J., Oniszczuk, T., Combrzyński, M., Kondracka, A., & Oniszczuk, A.
(2024). Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review. Metabolites, 14(6), 346.
https://doi.org/10.3390/metabo14060346